Search and visualization of gene-drug-disease interactions for pharmacogenomics and precision medicine research using GeneDive.
Biomedical information retrieval
Gene interactions
Gene sets
Gene-disease and gene-drug relationships
Retrieval and visualization
Journal
Journal of biomedical informatics
ISSN: 1532-0480
Titre abrégé: J Biomed Inform
Pays: United States
ID NLM: 100970413
Informations de publication
Date de publication:
05 2021
05 2021
Historique:
received:
23
09
2020
revised:
10
12
2020
accepted:
28
02
2021
pubmed:
20
3
2021
medline:
28
7
2021
entrez:
19
3
2021
Statut:
ppublish
Résumé
Understanding the relationships between genes, drugs, and disease states is at the core of pharmacogenomics. Two leading approaches for identifying these relationships in medical literature are: human expert led manual curation efforts, and modern data mining based automated approaches. The former generates small amounts of high-quality data, and the latter offers large volumes of mixed quality data. The algorithmically extracted relationships are often accompanied by supporting evidence, such as, confidence scores, source articles, and surrounding contexts (excerpts) from the articles, that can be used as data quality indicators. Tools that can leverage these quality indicators to help the user gain access to larger and high-quality data are needed. We introduce GeneDive, a web application for pharmacogenomics researchers and precision medicine practitioners that makes gene, disease, and drug interactions data easily accessible and usable. GeneDive is designed to meet three key objectives: (1) provide functionality to manage information-overload problem and facilitate easy assimilation of supporting evidence, (2) support longitudinal and exploratory research investigations, and (3) offer integration of user-provided interactions data without requiring data sharing. GeneDive offers multiple search modalities, visualizations, and other features that guide the user efficiently to the information of their interest. To facilitate exploratory research, GeneDive makes the supporting evidence and context for each interaction readily available and allows the data quality threshold to be controlled by the user as per their risk tolerance level. The interactive search-visualization loop enables relationship discoveries between diseases, genes, and drugs that might not be explicitly described in literature but are emergent from the source medical corpus and deductive reasoning. The ability to utilize user's data either in combination with the GeneDive native datasets or in isolation promotes richer data-driven exploration and discovery. These functionalities along with GeneDive's applicability for precision medicine, bringing the knowledge contained in biomedical literature to bear on particular clinical situations and improving patient care, are illustrated through detailed use cases. GeneDive is a comprehensive, broad-use biological interactions browser. The GeneDive application and information about its underlying system architecture are available at http://www.genedive.net. GeneDive Docker image is also available for download at this URL, allowing users to (1) import their own interaction data securely and privately; and (2) generate and test hypotheses across their own and other datasets.
Sections du résumé
BACKGROUND
Understanding the relationships between genes, drugs, and disease states is at the core of pharmacogenomics. Two leading approaches for identifying these relationships in medical literature are: human expert led manual curation efforts, and modern data mining based automated approaches. The former generates small amounts of high-quality data, and the latter offers large volumes of mixed quality data. The algorithmically extracted relationships are often accompanied by supporting evidence, such as, confidence scores, source articles, and surrounding contexts (excerpts) from the articles, that can be used as data quality indicators. Tools that can leverage these quality indicators to help the user gain access to larger and high-quality data are needed.
APPROACH
We introduce GeneDive, a web application for pharmacogenomics researchers and precision medicine practitioners that makes gene, disease, and drug interactions data easily accessible and usable. GeneDive is designed to meet three key objectives: (1) provide functionality to manage information-overload problem and facilitate easy assimilation of supporting evidence, (2) support longitudinal and exploratory research investigations, and (3) offer integration of user-provided interactions data without requiring data sharing.
RESULTS
GeneDive offers multiple search modalities, visualizations, and other features that guide the user efficiently to the information of their interest. To facilitate exploratory research, GeneDive makes the supporting evidence and context for each interaction readily available and allows the data quality threshold to be controlled by the user as per their risk tolerance level. The interactive search-visualization loop enables relationship discoveries between diseases, genes, and drugs that might not be explicitly described in literature but are emergent from the source medical corpus and deductive reasoning. The ability to utilize user's data either in combination with the GeneDive native datasets or in isolation promotes richer data-driven exploration and discovery. These functionalities along with GeneDive's applicability for precision medicine, bringing the knowledge contained in biomedical literature to bear on particular clinical situations and improving patient care, are illustrated through detailed use cases.
CONCLUSION
GeneDive is a comprehensive, broad-use biological interactions browser. The GeneDive application and information about its underlying system architecture are available at http://www.genedive.net. GeneDive Docker image is also available for download at this URL, allowing users to (1) import their own interaction data securely and privately; and (2) generate and test hypotheses across their own and other datasets.
Identifiants
pubmed: 33737208
pii: S1532-0464(21)00061-7
doi: 10.1016/j.jbi.2021.103732
pmc: PMC9042200
mid: NIHMS1792106
pii:
doi:
Substances chimiques
Pharmaceutical Preparations
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
103732Subventions
Organisme : NLM NIH HHS
ID : R01 LM005652
Pays : United States
Informations de copyright
Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.
Références
Lancet Oncol. 2015 Sep;16(9):1111-1122
pubmed: 26256760
Nat Rev Dis Primers. 2017 Mar 30;3:17016
pubmed: 28358037
Nature. 2003 Nov 27;426(6965):450-4
pubmed: 14647384
J Clin Invest. 2012 Oct;122(10):3424-31
pubmed: 23023713
Genome Res. 2003 Nov;13(11):2498-504
pubmed: 14597658
Clin Pharmacol Ther. 2012 Oct;92(4):414-7
pubmed: 22992668
Nature. 2015 Oct 15;526(7573):343-50
pubmed: 26469045
Methods Mol Biol. 2013;1015:311-20
pubmed: 23824865
Pac Symp Biocomput. 2015;:120-31
pubmed: 25592574
Eur J Intern Med. 2020 Jun;76:14-20
pubmed: 32336612
Curr Protoc Hum Genet. 2006 Nov;Chapter 6:Unit 6.10
pubmed: 18428394
Pharmacogenomics. 2012 Jan;13(2):201-12
pubmed: 22256869
BMC Bioinformatics. 2004 Feb 19;5:17
pubmed: 15028117
Mol Inform. 2011 Jun;30(6-7):506-19
pubmed: 27467152
Bioinformatics. 2014 Oct;30(19):2840-2
pubmed: 24939151
Nat Rev Dis Primers. 2015 Jul 23;1:15019
pubmed: 27189025
Pac Symp Biocomput. 2012;:410-21
pubmed: 22174296
Nucleic Acids Res. 2017 Jan 4;45(D1):D833-D839
pubmed: 27924018
Database (Oxford). 2013 Nov 28;2013:bat080
pubmed: 24288140
J Biol Chem. 2004 Jan 9;279(2):1570-4
pubmed: 14638696
Antioxid Redox Signal. 2012 Jan 1;16(1):57-70
pubmed: 21714724
Pac Symp Biocomput. 2018;23:590-601
pubmed: 29218917
J Biol Chem. 2005 Feb 25;280(8):7010-21
pubmed: 15591054
Nucleic Acids Res. 2017 Jan 4;45(D1):D985-D994
pubmed: 27899665
Clin Genet. 2014 Jul;86(1):21-8
pubmed: 24684508
Hum Genet. 2015 May;134(5):459-65
pubmed: 25238897
Bioinformatics. 2016 Jan 1;32(1):106-13
pubmed: 26338771
Bioinformatics. 2010 Sep 15;26(18):i547-53
pubmed: 20823320
Microbes Infect. 2009 Oct;11(12):912-8
pubmed: 19573617
Pharmacogenomics. 2010 Apr;11(4):501-5
pubmed: 20350130